8/12/2019 SA24PharmaMEA
1/4
More than half of the
Global Fortune 500
companies use BMIs
Reports to inform their
strategic planning and
business development
in emerging and
frontier markets. Join
them today, with the
protection of our 100%Money Back Guarantee!
(See back page for details).
Jonathan Feroze, Publisher,
Business Monitor International
Just published 30 Reports coveringMiddle East & Africastop
Pharmaceuticalsand Healthcaremarkets:
Q Algeria
Q Angola
Q Bahrain
Q Botswana
Q Cameroon
Q Cte dIvoire
Q Egypt
Q Gabon
Q Ghana
Q Iran
Q Iraq
Q Israel
Q Jordan
Q Kenya
Q Kuwait
Q Lebanon
Q Morocco
Q Mozambique
Q Namibia
Q Nigeria
Q Oman
Q Qatar
Q Saudi Arabia
Q South Africa
Q Sudan
Q Tanzania
Q UAE
Q Uganda
Q Zambia
Q Zimbabwe
www.businessmonitor.com/dm/pharma/middleeastafrica
If you have a PromotionCode please use itwhen ordering singleor
multiple Reports toreceive your discount.
Full price for a single Report is
US$1,295 / 985 / 810
Just Published
MALAYSIA
OILAND
GASREP
ORT
PUBLISH
EDBYBU
SINESSM
ONITOR
INTERN
ATIONAL
INDIAOILAND
GASREPORT
PUBLISHEDBYBU
SINESSMONITOR
INTERNATIONAL
PAKISTANOILANDGASREPORT
PUBLISHEDBYBUSINESSMONITORINTERNATIONAL
NIGERI
A
PHARM
ACEUTI
CALS&
HEALT
HCARE
REPORT
PUBLISH
EDBY
BUSINE
SSMONI
TORINT
ERNATIO
NAL
GHANA
PHARMAC
EUTICALS
&HEALTH
CARERE
PORT
PUBLISH
EDBYBU
SINESSMONITO
RINTERN
ATIONAL
JORDANPHARMACEUTIC
ALS&HEALTHCAREREPORT
PUBLISHEDBYBUSINESSMONIT
ORINTERNATIONAL
KUWAITPHARMACEUTICALS&HEALTHCAREREPORT
PUBLISHEDBYBUSINESSMONITORINTERNATIONAL
Middle East & AfricaPharmaceuticals &Healthcare
Reports
Q Benefit from the latest
market opportunitiesQ Protect your companyagainst future
risks
Q Prepare for theimpact of marketchanges
Q Know what yourcompetitorsare planning
Business Monitor Internationals Pharmaceuticals & Healthcare
Reports,
incorporating specialist insight from Espicom Business
Intelligence, provide
expert assessments on the outlook for 30 key markets across the
Middle
East & Africa. They reveal crucial opportunities for your
company and give
you invaluable insight to improve your operations and
investments.
Your choice of 30 Country Reports
8/12/2019 SA24PharmaMEA
3/4
To accessall this greatcontent turnthe page toorder
CONTENTS OF THE REPORTS:
Sample Report content
*Company profiles are not available for every country. Those
reports instead contain information on the current activities
of
prominent companies operating in the market.
Sources
The Pharmaceuticals & Healthcare Reports draw on an
extensive network of primary sources, such as
multinationalorganisations, government departments, industry
associations, chambers and company reports, including:
American Chamber of Commerce in EgyptAssociation of European
Self-Medication Industry (AESGP) IranMinistry of Health Jordan
Association Pharmaceutical of Manufacturers Jordan Food and Drug
Administration Kuwait Ministry of Health Lebanon Ministry of Health
Manufacturers Association of Israel (MAoI) MoroccoMinistry of
Health Nigeria Ministry of Health Oman Ministry of Health Qatar
Statistics Authority Saudi ArabiaMinistry of Health South African
Medical Database (SAMED) UN comtrade US Commercial Service USAID
-Assistance For Iraq World Health Organization (WHO)
4 Market SummaryA snapshot of key market
characteristics,including total size of the pharmaceuticalsand
healthcare segments, growth drivers,leading therapeutic areas and
the competitivelandscape.
5 Industry DevelopmentsA focus on government healthcare
reforms,
epidemiological trends, mergers andacquisitions, product
launches, marketentries, FDI activity, R&D,
biotechnology,clinical trials and supply chain issues.
6 Regulatory RegimeDetails of the industry regulatory
frameworkand key legislation covering the licensingof new
products/services, pricing andreimbursements, intellectual
property, taxationand advertising, as well as analysis of
theoverall regulatory burden.
7 Competitive LandscapeThe competitive landscape section
provides
comparative company analyses and rankingsby US$ sales and %
share of total sales forthe total pharmaceutical sector, as well as
theOTC, generics and distribution sub-sectors.
8 Company Profiles*Examines the competitive positioning
andshort- to medium-term business strategies ofkey industry
players. Strategy is examined withinthe context of BMIs industry
forecasts, ourmacroeconomic views and our understandingof the wider
competitive landscape to generateCompany SWOT analyses. The latest
financialand operating statistics and key companydevelopments are
also incorporated within thecompany profiles, enabling a full
evaluation ofrecent company performance and future
growthprospects.
Our profiles give you importantinsight on key market
players,including:
Aspen Pharmacare
Bader Sultan & Bros
Exir Pharmaceuticals
GlaxoSmithKline
Gulf Pharmaceutical Industries (Julphar)
Johnson & Johnson
1 BMI Industry ViewAn at-a-glance perspective on the
latestregulatory developments, key forecastindicators and major
corporate developments,covering the prescription, OTC and
genericsmarkets. The pharmaceuticals and healthcareSWOT outlines
strategic factors that affectthe basic assumptions underpinning
BMIsforecast analysis, and taken together with
BMIs political, economic and businessenvironment SWOTs, it gives
a completeoverview of market climate.
2 BMI Industry Forecast ScenarioIndustry forecasts to end-2018
for all keyindicators, supported by explicit assumptions,plus
analysis of key downside risks to themain forecasts:
Healthcare:Total healthcare expenditure(US$bn), healthcare
expenditure (% of GDP),healthcare expenditure per capita
(US$),hospital beds, doctors, and birth & mortalityrates (all
per 000 population).
Pharmaceutical market:Drug expenditurein US$bn, % of GDP and per
capita (US$).
Patented drug market:Prescription drugsales (US$bn & % of
total sales), sales brokendown by 14 therapeutic areas
(cardiovascular,anti-infectives etc.).
Generic drug market:Generic product sales(US$bn), generic sales
(% of total sales).
OTC drug market:OTC sales (US$bn & %of total sales), sales
broken down by producttypes (analgesics, skin treatments,
vitaminsand minerals etc.).
Medical devices:Medical device sales(US$bn), medical device
sales (% of total
healthcare market).
Macroeconomic forecasts:Nominal andreal GDP, % real GDP growth,
% privateconsumption growth, % industrial outputgrowth, % consumer
price index, % GDPprice deflator, exports, imports, trade
balance,current account balance, foreign directinvestment, exchange
rate against US$,government expenditure and external debt.
3 BMIs Pharmaceuticals andHealthcare Risk Reward RatingsBMIs
Risk Reward Ratings provide investors(both national and
multinational) looking for
opportunities in the region with a clear country-comparative
assessment of the markets risksand potential rewards. Each of the
30 countrymarkets are scored using a sophisticatedmodel that
includes more than 40 industry,economic and demographic data points
toprovide a ranking of highest to lowest appealto investors, with
each ranking explained.
8/12/2019 SA24PharmaMEA
4/4
Fax your order to +44 (0) 20 7248 0467
Email your order [email protected]
Call our Customer Services team on+44 (0) 20 7246 1403 to
discussyour information needs and for special discounts on
multi-report orders.
Send your order to:
Business Monitor InternationalSenator House,85 Queen Victoria
Street,London, EC4V 4AB, UK
FIVEeasy ways to order
Our complete portfolio of Pharmaceuticals & Healthcare
Reports covers 96 countries across the globe.
www.businessmonitor.com/dm/pharma/global
On processing your order you will be sent the Report in print by
airmail,along with 3 free PDF quarterly updates over the next 12
months.
For instant access to your Reports simply order online at:
www.businessmonitor.com/dm/pharma/middleeastafrica
To receive your Pharmaceuticals & Healthcare Reports use any
of the following ways to order.
And if you have a Promotion Code please use it when ordering to
receive your discountfrom the full Report price of US$1,295 / 985 /
810.
